Tag Archives | BIIB

Biogen 2018 Proxy Voting Recommendations

The Biogen 2018 annual meeting is June 12. I voted AGAINST several directors and the pay package. Vote FOR the auditor and both shareholder proposals to enhance value.

Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. Most shareholders do not vote because reading through 80+ pages of the proxy is not worth the time for the small difference your vote will make. Below, I tell you how I am voting and why.

If you have read these posts related to my portfolio for the last 22 years, have values aligned with mine, and trust my judgment, go immediately to see how I voted my ballot. Voting will take you only a minute or two and every vote counts.

I voted with the Board’s recommendations 57% of the time. View Proxy Statement via SEC’s EDGAR system (look for DEF 14A). Continue Reading →

Continue Reading ·

Biogen (BIIB): Proxy Score 47 – Proxy Access Victory

Biogen IdecBiogen Inc. (BIIB) discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It is one of the stocks in my portfolio. Their annual meeting is coming up on 6/10/2015. ProxyDemocracy.org had the vote of five funds (removed 2nd Calvert from table below, since it was duplicative) when I checked and voted on 6/4/2015.  I voted with management 47% of the time and assigned Biogen a proxy score of 47. Continue Reading →

Continue Reading ·

Proxy Access Win at Biogen & Other Efforts in 2015

Proxy Access in the USMy wife and I don’t have the resources to or stock holdings to allow us to file 75 proxy access shareholder proposals, like New York City Comptroller Scott Stringer’s Boardroom Accountability Project. However, I have been writing about proxy access for 20 years and, together with Les Greenberg, filed the petition in 2002 with the SEC that many have credited with renewing interest in the subject. We hope our efforts, although small, contribute to making companies more democratic and profitable. Continue Reading →

Continue Reading ·

David Harvey & Gar Alperovitz on Sustainable Capitalism

Gar Alperovitz

Gar Alperovitz

Sustainable capitalism, or is that even possible? David Harvey and Gar Alperovitz dig into the failure of capitalism, the hope presented by worker co-ops, and what activists fighting for a just economy must do to get there. You could say they are living in a dream-world, but isn’t it be a nice one? We can change the economy to work for everyone but powerful forces are lined up against any such changes.  Continue Reading →

Continue Reading ·

Biogen Idec, $BIIB: Proxy Vote

BIIBBiogen Idec, $BIIB, is one of the stocks in my portfolio. Their annual meeting is June 12, 2014. ProxyDemocracy.org had collected the votes of four funds when I checked and voted on 6/10/2014. ProxyDemocracy.org now has collected the votes of five funds.  I voted with management 46% of the time.  View Proxy Statement. Read Warnings below. What follows are my recommendations on how to vote the BIIB proxy in order to enhance corporate governance and long-term value.   Continue Reading →

Continue Reading ·

Powered by WordPress. Designed by WooThemes